U.S. Patient Stories

Hannah's Story

Issue link: https://hub.orionhealth.com/i/933476

Contents of this Issue

Navigation

Page 0 of 0

Avoiding a Costly Antidote's Second Dose A Patient Story Revolutionizing Healthcare, One Patient at a Time When 3-year-old Hannah's parents—who lived in a remote, rural part of New Mexico—realized their daughter had drunk a bottle of antifreeze, they immediately called 9-1-1. Paramedics arrived 30 minutes later and rushed Hannah to Albuquerque. While en route, they contacted the New Mexico Poison and Drug Information Center (NMPDIC). The paramedics provided the certified specialist in poison information (CSPI) on duty at NMPDIC with Hannah's name and date of birth, after which the CSPI began explaining how to treat poisoning by ethylene glycol, the deadly active ingredient in antifreeze. But as the ambulance sped through rural New Mexico, the call dropped. Luckily, with the patient's name and date of birth in hand, the CSPI was able to locate Hannah with the Orion Health Clinical Portal and the New Mexico Health Information Collaborative (NMHIC), an HIE; identify which emergency room Hannah had been taken to; and call them to finish explaining the protocol needed for treatment. Ethylene glycol poisoning has a very specific antidote. Each dose costs $1,300, and it only reverses ethylene glycol's effects for about 12 hours. If administered promptly after ingestion, the patient won't experience any severe side effects, which can include coma, kidney failure, and death. With the Clinical Portal, the CSPIs at NMPDIC were able to follow up with Hannah's ER physicians, make the appropriate recommendation, and order blood tests to assess the need for ongoing treatment. However, there is only one laboratory in New Mexico equipped to test for ethylene glycol, and the test takes six to eight hours to produce results, which often prompts care givers to administer a second dose to poisoned patients. But because the CSPIs had access to the HIE, they saw Hannah's test results the moment they were available and determined that Hannah would not be needing a second dose and could, in fact, be sent home. "The change in our ability to look at these labs and follow these patients has made our lives so much easier," said LaDonna Bonnin, a registered pharmacist (RPh) and CSPI at NMPDIC. Without access to the HIE, the CSPIs would have had to call the laboratory every hour to see if the results were in, wasting both their and the laboratory staff's time. Without the results coming in in real time, the CSPIs would've been forced to recommend another costly, unnecessary dose, just to be safe. But with the help of the HIE, the CSPIs were able to do more than just follow up after the call had been dropped and recommend appropriate treatment—they were actually able to verify the treatment's efficacy. Streamlining poison control efforts and allowing a 3-year-old to spend the night in her own bed is just another way Orion Health is revolutionizing healthcare, one patient at a time. Future-proof your journey from population health to precision medicine. Find out more at orionhealth.com Orion Health™ is a trademark of Orion Health group of companies. All other trademarks displayed in this document are the property of Orion Health or their respective owners, and may not be used without written permission of the owner. All patient information shown in any imagery is for representation and demonstration purposes only and is not related to a real patient. Orion Health makes no warranties and the functionality described within may change without notice. Copyright © 2017 Orion Health™ group of companies | All rights reserved | www.orionhealth.com Hannah and Meg - The Patient Story_102017

Articles in this issue

Links on this page

view archives of U.S. Patient Stories - Hannah's Story